P08183 (MDR1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 158.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Multidrug resistance protein 1 EC=3.6.3.44 Alternative name(s): ATP-binding cassette sub-family B member 1 P-glycoprotein 1 CD_antigen=CD243 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1280 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells. |
| Catalytic activity | ATP + H2O + xenobiotic(In) = ADP + phosphate + xenobiotic(Out). |
| Subunit structure | Interacts with PSMB5. Ref.10 |
| Subcellular location | Cell membrane; Multi-pass membrane protein By similarity. |
| Tissue specificity | Expressed in liver, kidney, small intestine and brain. |
| Polymorphism | Genetic variation in ABCB1 may play a role in patients who do not respond to drug treatment. |
| Involvement in disease | Inflammatory bowel disease 13 (IBD13) [MIM:612244]: A chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. |
| Sequence similarities | Belongs to the ABC transporter superfamily. ABCB family. Multidrug resistance exporter (TC 3.A.1.201) subfamily. [View classification] Contains 2 ABC transmembrane type-1 domains. Contains 2 ABC transporter domains. |
| Sequence caution | The sequence AAM49149.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| LAPTM4B | Q86VI4 | 2 | EBI-1057359,EBI-3267258 | |
| RNF2 | Q99496 | 2 | EBI-1057359,EBI-722416 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1280 | 1280 | Multidrug resistance protein 1 | PRO_0000093332 | |||||
Regions | |||||||||
| Topological domain | 1 – 44 | 44 | Cytoplasmic By similarity | ||||||
| Transmembrane | 45 – 67 | 23 | Helical; Potential | ||||||
| Topological domain | 68 – 116 | 49 | Extracellular By similarity | ||||||
| Transmembrane | 117 – 137 | 21 | Helical; Potential | ||||||
| Topological domain | 138 – 186 | 49 | Cytoplasmic By similarity | ||||||
| Transmembrane | 187 – 208 | 22 | Helical; Potential | ||||||
| Topological domain | 209 – 215 | 7 | Extracellular By similarity | ||||||
| Transmembrane | 216 – 236 | 21 | Helical; Potential | ||||||
| Topological domain | 237 – 292 | 56 | Cytoplasmic By similarity | ||||||
| Transmembrane | 293 – 316 | 24 | Helical; Potential | ||||||
| Topological domain | 317 – 330 | 14 | Extracellular By similarity | ||||||
| Transmembrane | 331 – 352 | 22 | Helical; Potential | ||||||
| Topological domain | 353 – 711 | 359 | Cytoplasmic By similarity | ||||||
| Transmembrane | 712 – 732 | 21 | Helical; Potential | ||||||
| Topological domain | 733 – 756 | 24 | Extracellular By similarity | ||||||
| Transmembrane | 757 – 777 | 21 | Helical; Potential | ||||||
| Topological domain | 778 – 832 | 55 | Cytoplasmic By similarity | ||||||
| Transmembrane | 833 – 853 | 21 | Helical; Potential | ||||||
| Topological domain | 854 | 1 | Extracellular By similarity | ||||||
| Transmembrane | 855 – 874 | 20 | Helical; Potential | ||||||
| Topological domain | 875 – 934 | 60 | Cytoplasmic By similarity | ||||||
| Transmembrane | 935 – 957 | 23 | Helical; Potential | ||||||
| Topological domain | 958 – 973 | 16 | Extracellular By similarity | ||||||
| Transmembrane | 974 – 995 | 22 | Helical; Potential | ||||||
| Topological domain | 996 – 1280 | 285 | Cytoplasmic By similarity | ||||||
| Domain | 51 – 357 | 307 | ABC transmembrane type-1 1 | ||||||
| Domain | 392 – 628 | 237 | ABC transporter 1 | ||||||
| Domain | 711 – 1000 | 290 | ABC transmembrane type-1 2 | ||||||
| Domain | 1035 – 1273 | 239 | ABC transporter 2 | ||||||
| Nucleotide binding | 427 – 434 | 8 | ATP 1 By similarity | ||||||
| Nucleotide binding | 1070 – 1077 | 8 | ATP 2 By similarity | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 91 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 94 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 99 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 17 | 1 | F → L. Ref.4 Corresponds to variant rs28381804 [ dbSNP | Ensembl ]. | VAR_022276 | |||||
| Natural variant | 21 | 1 | N → D. Ref.4 Ref.5 Ref.15 Ref.16 Ref.17 Corresponds to variant rs9282564 [ dbSNP | Ensembl ]. | VAR_014704 | |||||
| Natural variant | 44 | 1 | N → S. Corresponds to variant rs1202183 [ dbSNP | Ensembl ]. | VAR_055423 | |||||
| Natural variant | 80 | 1 | A → E. Corresponds to variant rs9282565 [ dbSNP | Ensembl ]. | VAR_055424 | |||||
| Natural variant | 103 | 1 | F → L Rare polymorphism. Ref.16 | VAR_015001 | |||||
| Natural variant | 108 | 1 | E → K. Ref.18 | VAR_018351 | |||||
| Natural variant | 185 | 1 | G → V in a colchicine-selected multidrug-resistant cell line; confers increased resistance to colchicine. Ref.1 Ref.3 Ref.13 Corresponds to variant rs1128501 [ dbSNP | Ensembl ]. | VAR_015002 | |||||
| Natural variant | 261 | 1 | I → V. Corresponds to variant rs36008564 [ dbSNP | Ensembl ]. | VAR_055425 | |||||
| Natural variant | 400 | 1 | S → N. Ref.4 Ref.16 Ref.17 Corresponds to variant rs2229109 [ dbSNP | Ensembl ]. | VAR_015003 | |||||
| Natural variant | 566 | 1 | E → K. Ref.4 Corresponds to variant rs28381902 [ dbSNP | Ensembl ]. | VAR_022277 | |||||
| Natural variant | 593 | 1 | R → C. Ref.4 Corresponds to variant rs28381914 [ dbSNP | Ensembl ]. | VAR_022278 | |||||
| Natural variant | 599 | 1 | A → T. Corresponds to variant rs2235036 [ dbSNP | Ensembl ]. | VAR_055426 | |||||
| Natural variant | 669 | 1 | R → C. Corresponds to variant rs35023033 [ dbSNP | Ensembl ]. | VAR_055427 | |||||
| Natural variant | 801 | 1 | V → M. Corresponds to variant rs2235039 [ dbSNP | Ensembl ]. | VAR_055428 | |||||
| Natural variant | 829 | 1 | I → V. Corresponds to variant rs2032581 [ dbSNP | Ensembl ]. | VAR_055429 | |||||
| Natural variant | 836 | 1 | I → V. Ref.4 Corresponds to variant rs28381967 [ dbSNP | Ensembl ]. | VAR_022279 | |||||
| Natural variant | 887 | 1 | K → N in a colorectal cancer sample; somatic mutation. Ref.23 | VAR_035737 | |||||
| Natural variant | 893 | 1 | S → A Common allele; associated with susceptibility to IBD13; has decreased enzyme activity. Ref.1 Ref.2 Ref.3 Ref.4 Ref.14 Ref.17 Ref.20 Ref.21 Corresponds to variant rs2032582 [ dbSNP | Ensembl ]. | VAR_013361 | |||||
| Natural variant | 893 | 1 | S → T Rare allele. Ref.17 Ref.20 Ref.21 Corresponds to variant rs2032582 [ dbSNP | Ensembl ]. | VAR_013362 | |||||
| Natural variant | 986 | 1 | M → V. | VAR_018352 | |||||
| Natural variant | 999 | 1 | A → T. Ref.14 | VAR_015004 | |||||
| Natural variant | 1051 | 1 | P → A. Ref.4 Corresponds to variant rs28401798 [ dbSNP | Ensembl ]. | VAR_022280 | |||||
| Natural variant | 1107 | 1 | Q → P. Ref.17 Corresponds to variant rs55852620 [ dbSNP | Ensembl ]. | VAR_015005 | |||||
| Natural variant | 1141 | 1 | S → T. Ref.4 Corresponds to variant rs2229107 [ dbSNP | Ensembl ]. | VAR_022281 | |||||
| Natural variant | 1251 | 1 | V → I. Ref.4 Ref.19 Corresponds to variant rs28364274 [ dbSNP | Ensembl ]. | VAR_018353 | |||||
Experimental info | |||||||||
| Sequence conflict | 23 | 1 | S → R in CAA41558. Ref.8 | ||||||
| Sequence conflict | 336 | 1 | Missing in AAB69423. Ref.3 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells." Chen C.-J., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., Roninson I.B. Cell 47:381-389(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS VAL-185 AND ALA-893. |
| [2] | "Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins." Chen C.-J., Clark D.P., Ueda K., Pastan I., Gottesman M.M., Roninson I.B. J. Biol. Chem. 265:506-514(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT ALA-893. |
| [3] | "Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins." Chen G., Duran G.E., Steger K.A., Lacayo N.J., Jaffrezou J.P., Dumontet C., Sikic B.I. J. Biol. Chem. 272:5974-5982(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS VAL-185 AND ALA-893. |
| [4] | NIEHS SNPs program Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LEU-17; ASP-21; ASN-400; LYS-566; CYS-593; VAL-836; ALA-893; ALA-1051; THR-1141 AND ILE-1251. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ASP-21. Tissue: Thalamus. |
| [6] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles." Gekeler V., Weger S., Probst H. Biochem. Biophys. Res. Commun. 169:796-802(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 178-215 AND 800-856. |
| [8] | "P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance." Kioka N., Tsubota J., Kakehi Y., Komano T., Gottesman M.M., Pastan I., Ueda K. Biochem. Biophys. Res. Commun. 162:224-231(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-23. |
| [9] | "ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2." Kerb R., Hoffmeyer S., Brinkmann U. Pharmacogenomics 2:51-64(2001) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| [10] | "Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome." Begley G.S., Horvath A.R., Taylor J.C., Higgins C.F. Mol. Immunol. 42:137-141(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PSMB5. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [12] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene." Choi K.H., Chen C.-J., Kriegler M., Roninson I.B. Cell 53:519-529(1988) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VAL-185. |
| [14] | "Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors." Mickley L.A., Lee J.-S., Weng Z., Zhan Z., Alvarez M., Wilson W., Bates S.E., Fojo T. Blood 91:1749-1756(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALA-893 AND THR-999. |
| [15] | "A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein." Decleves X., Chevillard S., Charpentier C., Vielh P., Laplanche J.-L. Hum. Mutat. 15:486-486(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ASP-21. |
| [16] | "Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo." Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoeller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Proc. Natl. Acad. Sci. U.S.A. 97:3473-3478(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASP-21; LEU-103 AND ASN-400. |
| [17] | "Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects." Cascorbi I., Gerloff T., Johne A., Meisel C., Hoffmeyer S., Schwab M., Schaeffeler E., Eichelbaum M., Brinkmann U., Roots I. Clin. Pharmacol. Ther. 69:169-174(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ASP-21; ASN-400; ALA-893; THR-893 AND PRO-1107. |
| [18] | "Polymorphism of MDR1 gene in healthy Japanese subjects: a novel SNP with an amino acid substitution (Glu108Lys)." Honda T., Dan Y., Koyabu N., Ieiri I., Otsubo K., Higuchi S., Ohtani H., Sawada J. Drug Metab. Pharmacokinet. 17:479-481(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT LYS-108. |
| [19] | "Twelve novel single nucleotide polymorphisms in ABCB1/MDR1 among Japanese patients with ventricular tachycardia who were administered amiodarone." Itoda M., Saito Y., Komamura K., Ueno K., Kamakura S., Ozawa S., Sawada J. Drug Metab. Pharmacokinet. 17:566-571(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ILE-1251. |
| [20] | "Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population." Saito S., Iida A., Sekine A., Miura Y., Ogawa C., Kawauchi S., Higuchi S., Nakamura Y. J. Hum. Genet. 47:38-50(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALA-893 AND THR-893. |
| [21] | "MDR1 Ala893 polymorphism is associated with inflammatory bowel disease." Brant S.R., Panhuysen C.I.M., Nicolae D., Reddy D.M., Bonen D.K., Karaliukas R., Zhang L., Swanson E., Datta L.W., Moran T., Ravenhill G., Duerr R.H., Achkar J.-P., Karban A.S., Cho J.H. Am. J. Hum. Genet. 73:1282-1292(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ALA-893 AND THR-893, ASSOCIATION WITH SUSCEPTIBILITY TO IBD13. |
| [22] | Erratum Brant S.R., Panhuysen C.I.M., Nicolae D., Reddy D.M., Bonen D.K., Karaliukas R., Zhang L., Swanson E., Datta L.W., Moran T., Ravenhill G., Duerr R.H., Achkar J.-P., Karban A.S., Cho J.H. Am. J. Hum. Genet. 74:1080-1080(2004) |
| [23] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] ASN-887. |
| + | Additional computationally mapped references. |
Web resources
| Atlas of Genetics and Cytogenetics in Oncology and Haematology |
| NIEHS-SNPs |
| SHMPD The Singapore human mutation and polymorphism database |
| Wikipedia P-glycoprotein entry |
| ABCMdb Database for mutations in ABC proteins |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | M14758 mRNA. Translation: AAA59575.1. M29447 M29446 Genomic DNA. Translation: AAA59576.1.AF016535 mRNA. Translation: AAB69423.1. AY910577 Genomic DNA. Translation: AAW82430.1. AK290159 mRNA. Translation: BAF82848.1. AC002457 Genomic DNA. Translation: AAM49149.1. Sequence problems. AC005068 Genomic DNA. No translation available. M37724 Genomic DNA. Translation: AAA88047.1. M37725 Genomic DNA. Translation: AAA88048.1. X58723 Genomic DNA. Translation: CAA41558.1. |
| IPI | IPI00027481. |
| PIR | DVHU1. A34914. |
| RefSeq | NP_000918.2. NM_000927.4. |
| UniGene | Hs.489033. Hs.737655. |
3D structure databases | |
| ProteinModelPortal | P08183. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P08183. 6 interactions. |
| MINT | MINT-5000901. |
| STRING | 9606.ENSP00000265724. |
Protein family/group databases | |
| TCDB | 3.A.1.201.1. ATP-binding cassette (ABC) superfamily. |
PTM databases | |
| PhosphoSite | P08183. |
Polymorphism databases | |
| DMDM | 238054374. |
Proteomic databases | |
| PaxDb | P08183. |
| PRIDE | P08183. |
Protocols and materials databases | |
| DNASU | 5243. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000265724; ENSP00000265724; ENSG00000085563. |
| GeneID | 5243. |
| KEGG | hsa:5243. |
| UCSC | uc003uiz.2. human. |
Organism-specific databases | |
| CTD | 5243. |
| GeneCards | GC07M087132. |
| H-InvDB | HIX0033521. |
| HGNC | HGNC:40. ABCB1. |
| HPA | CAB001716. HPA002199. |
| MIM | 120080. phenotype. 171050. gene. 612244. phenotype. |
| neXtProt | NX_P08183. |
| PharmGKB | PA267. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG1132. |
| HOVERGEN | HBG080809. |
| InParanoid | P08183. |
| KO | K05658. |
| OMA | TGLASDQ. |
| OrthoDB | EOG42FSGR. |
| PhylomeDB | P08183. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | hif1_tfpathway. HIF-1-alpha transcription factor network. |
| Reactome | REACT_111217. Metabolism. REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | P08183. |
| Bgee | P08183. |
| CleanEx | HS_ABCB1. |
| Genevestigator | P08183. |
| GermOnline | ENSG00000085563. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR003593. AAA+_ATPase. IPR003439. ABC_transporter-like. IPR017871. ABC_transporter_CS. IPR017940. ABC_transporter_type1. IPR001140. ABC_transptr_TM_dom. IPR011527. ABC_transptrTM_dom_typ1. [Graphical view] |
| Pfam | PF00664. ABC_membrane. 2 hits. PF00005. ABC_tran. 2 hits. [Graphical view] |
| SMART | SM00382. AAA. 2 hits. [Graphical view] |
| SUPFAM | SSF90123. ABC_TM_1. 2 hits. |
| PROSITE | PS50929. ABC_TM1F. 2 hits. PS00211. ABC_TRANSPORTER_1. 2 hits. PS50893. ABC_TRANSPORTER_2. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P08183. |
| ChEMBL | CHEMBL4302. |
| DrugBank | DB00171. Adenosine triphosphate. DB00802. Alfentanil. DB01169. Arsenic trioxide. DB01072. Atazanavir. DB01136. Carvedilol. DB01394. Colchicine. DB00091. Cyclosporine. DB00694. Daunorubicin. DB00975. Dipyridamole. DB01196. Estramustine. DB00875. Flupenthixol. DB00619. Imatinib. DB01167. Itraconazole. DB00622. Nicardipine. DB01182. Propafenone. DB01103. Quinacrine. DB00908. Quinidine. DB00243. Ranolazine. DB01045. Rifampin. DB00778. Roxithromycin. DB01232. Saquinavir. DB00675. Tamoxifen. DB00570. Vinblastine. |
| GenomeRNAi | 5243. |
| NextBio | 20254. |
| SOURCE | Search... |
Entry information
| Entry name | MDR1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P08183 Secondary accession number(s): A8K294, Q12755, Q14812 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Recent format changes Overview of recent format changes |
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
